US 8497301
Hydroxyl compounds and compositions for cholesterol management and related uses
granted A61KA61K31/191A61K31/194
Quick answer
US patent 8497301 (Hydroxyl compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Esperion Therapeutics, Inc.
- Grant date
- Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/191, A61K31/194, A61K31/20, A61K31/23